New Indication of Olverembatinib Included into China 2024 National Reimbursement Drug List
ROCKVILLE,Md. andSUZHOU,China,Nov. 28,2024-- Ascentage Pharma (6855.HK),a global biopharmaceutical company engaged in discovering,developing and commercializing therapies to address global unmet medi